Compare Automatic Data Processing Inc (ADP) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Automatic Data Processing Inc vs Novo Nordisk A/S — how do they compare? Automatic Data Processing Inc trades at $268.3 (market cap $107.69B), while Novo Nordisk A/S trades at $46.18 (market cap $207.85B). The key difference: Novo Nordisk A/S is the larger of the two by market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| ADP | NVO | |
|---|---|---|
Market Cap | $107.69B | $207.85B |
Sector | Industrials | Health |
52-Week High | $309.03 | $63.98 |
52-Week Low | $188.79 | $35.29 |
Enterprise Value | $108.73B | $222.55B |
Dividend Yield | 2.51% | 3.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADP trades at $273.68, up 0.87% today, near its consensus price target of $280.50. The stock shows bullish technical signals with strong moving averages and support at $270. Recent quarterly earnings consistently beat estimates, with Q2 2026 EPS of $2.64 surpassing the $2.59 forecast. Revenue growth is steady, reaching $20.56 billion in 2025, with a net income margin of 20.11% and robust ROE of 72.24%.
Outlook remains positive given earnings momentum and dividend stability, but high valuation multiples (P/E 24.78, P/S 4.98) pose risks if growth slows. Analyst sentiment is mixed with 63.89% hold ratings, reflecting caution amid elevated prices. Key risks include labor market sensitivity and competitive pressures in payroll processing.
NVO trades at $47.73, up 0.99% today, with a neutral technical signal and strong fundamentals, including a P/E of 11.62 and net income margin of 35.35%. Recent Q2 2026 earnings beat expectations, but the stock faces mixed sentiment due to competitive pressures and pricing headwinds in its GLP-1 portfolio.
The outlook is cautiously optimistic, supported by robust profitability and analyst buy ratings (57.9%), but risks include intense competition from Eli Lilly and margin compression. Upside potential hinges on execution against guidance, while downside risks stem from market share erosion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Automatic Data Processing Inc
ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.
Read more on ADP →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
